olaparib,abiraterone
merck,astrazeneca,janssen
['olaparib', 'abiraterone', 'prostate', 'crpc', 'brca', 'brcaaway']
join maha h.a. hussain, md, fasco, facp, for session, brcaaway: a randomized phase 2 trial of abiraterone, olaparib, or abiraterone + olaparib in patients with metastatic castration-resistant prostate cancer (mcrpc) with dna repair defects, at #asco22 
@LurieCancer at Northwestern Memorial Hospital, ranked No. 6 in U.S. by @USNews. Translating leading-edge discoveries into better cancer care.